View Expired Tender

Get immediate access to tenders like the one below by subscribing now to Tenders Direct. We will set up your personalised profile and send you tender alerts direct to your mailbox as soon as they are published. You will also benefit from having access to historical tenders.

Notice Summary

Title:
United Kingdom-Birmingham: Framework Agreement for the Supply of Contrast Media, Injectors and Associated Consumables
Document Ref:
58065-2020
Document Type:
Contract Notice - Open Procedure
Published By:
HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Cov
Date Published:
05 February 2020
Deadline Date:
02 March 2020
Document Source:
Framework/DPS:
Yes
Alert Profile:
Labels:

Notice Abstract

HealthTrust Europe is seeking to establish a multi-lot framework agreement for the supply of contrast media, injectors and associated consumables. The contrast media helps to contrast selected areas of the body from the surrounding tissue. It enables visibility of specific organs, blood vessels or tissues to help diagnose a range of conditions. Suppliers must possess the ability and licenses to deliver these products.The lots being tendered are:Lot 1:Contrast Media and Associated Consumables;Lot 2: Contrast Injectors and Associated Consumables;Lot 3: Mini-Competition Lot.

Notice Details

Contract notice

Directive 2014/24/EU - Public Sector Directive

Directive 2014/24/EU

Section I: Contracting entity

I.1) Name and addresses

HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (‘UHCW’)

19 George Road, Edgbaston

Birmingham

B15 1NU

UK

Contact person: Aisha Shehzad

Telephone: +44 8458875000

E-mail: Aisha.Shehzad@htepg.com

NUTS: UK

Internet address(es)

Main address: https://healthtrusteurope.bravosolution.co.uk

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://healthtrusteurope.bravosolution.co.uk


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://healthtrusteurope.bravosolution.co.uk


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Framework Agreement for the Supply of Contrast Media, Injectors and Associated Consumables

Reference number: SF051629

II.1.2) Main CPV code

33696000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

HealthTrust Europe is seeking to establish a multi-lot framework agreement for the supply of contrast media, injectors and associated consumables. The contrast media helps to contrast selected areas of the body from the surrounding tissue. It enables visibility of specific organs, blood vessels or tissues to help diagnose a range of conditions. Suppliers must possess the ability and licenses to deliver these products.

The lots being tendered are:

Lot 1:Contrast Media and Associated Consumables;

Lot 2: Contrast Injectors and Associated Consumables;

Lot 3: Mini-Competition Lot.

II.1.5) Estimated total value

Value excluding VAT: 20 000 000.00 GBP

II.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

Maximum number of lots that may be awarded to one tenderer: 3

II.2) Description

Lot No: 1

II.2.1) Title

Lot 1: Contrast Media and Associated Consumables

II.2.2) Additional CPV code(s)

33696800

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Lot 1, supplies under this lot are intended to improve the visibility of internal organs and structures in X-ray imaging with the use of computed tomography (CT), magnetic resonance imaging (MRI) and/or ultrasound. Suppliers must possess the ability and relevant licenses to store, transport and deliver contrast media and any associated consumables, which shall include but not limited to:

— iodine based contrast agents; Ionic and Non-ionic,

— barium-sulphate,

— gadolinium,

— saline, and

— associated consumables.

Terms and conditions/activity based income (ABI)

The terms and conditions of this framework agreement and any resulting call-off contract is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this framework agreement, the management and administration by HTE of the overall contract structure and associated documentation, as well as the requirement to submit regular management information to HTE.

Submission of expressions of interest and procurement information

This exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows: Register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk Login to the portal with username/password. Click the SQs/ITTs Open to All Suppliers link. These are the SQs/ITTs open to any registered supplier. Click on the relevant SQ/ ITT to access the content. Click the Express Interest button at the top of the page. This will move the SQ/ITT into your My SQs/My ITTs page. You can access any attachments by clicking Buyer Attachments in the SQ/ITT Details box. Follow the onscreen instructions to complete the SQ/ITT. Submit your reply using the Submit Response button at the top of the page. If you require any further advice, contact the Bravo eTendering Help Desk at help@bravosolution.co.uk Sid4Gov HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at sid4gov@gps.gsi.gov.uk

Please note that sid4gov does not pre-populate any fields of the SQ on HTE's Bravo portal. Candidates must complete the qualification and technical envelopes of the SQ in Bravo in full.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6) Estimated value

Value excluding VAT: 2 000 000.00 GBP

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24

This contract is subject to renewal: Yes

Description of renewals:

The framework agreement resulting from this procurement process will remain in force for an initial period of 2 years and subject to approval by HealthTrust Europe may be extended for up to a 24-month period thereafter.

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

The framework agreement resulting from this procurement process will remain in force for an initial period of 2 years and subject to approval by HealthTrust Europe may be extended for up to a 24-month period thereafter.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

Lot 2: Contrast Injectors and Associated Consumables

II.2.2) Additional CPV code(s)

33110000

33111000

33140000

33141310

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Lot 2: Contrast Injectors

This lot will incorporate the provision of contrast injectors and associated consumables. These products are medical devices intended for use in imaging and the administration of contrast to patients that can allow for enteral, parenteral and/or other routes of administration.

Suppliers must possess the ability and licenses to store, transport and deliver injector equipment and any associated technologies and or consumables which shall include but not limited to:

— contrast injectors,

— associated consumables, equipment and services.

TErms and conditions. Activity based income (ABI)

The terms and conditions of this framework agreement and any resulting call-off contract is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this framework agreement, the management and administration by HTE of the overall contract structure and associated documentation, as well as the requirement to submit regular management information to HTE.

Submission of expressions of interest and procurement information

This exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows: register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk Login to the portal with username/password. Click the SQs/ITTs Open to All Suppliers link. These are the SQs/ITTs open to any registered supplier. Click on the relevant SQ/ ITT to access the content. Click the Express Interest button at the top of the page. This will move the SQ/ITT into your My SQs/My ITTs page. You can access any attachments by clicking Buyer Attachments in the SQ/ITT Details box. Follow the onscreen instructions to complete the SQ/ITT. Submit your reply using the Submit Response button at the top of the page. If you require any further advice, contact the Bravo eTendering Help Desk at help@bravosolution.co.uk Sid4Gov HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at sid4gov@gps.gsi.gov.uk Please note that sid4gov does not pre-populate any fields of the SQ on HTE's Bravo portal. HTE reserves the right to reject bids, products or services where it is deemed inappropriate, irrelevant or incompatible. Candidates must complete the qualification and technical envelopes of the SQ in Bravo in full.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6) Estimated value

Value excluding VAT: 5 000 000.00 GBP

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24

This contract is subject to renewal: Yes

Description of renewals:

The framework agreement resulting from this procurement process will remain in force for an initial period of 2 years and subject to approval by HealthTrust Europe may be extended for up to a 24-month period thereafter.

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

The framework agreement resulting from this procurement process will remain in force for an initial period of 2 years and subject to approval by HealthTrust Europe may be extended for up to a 24-month period thereafter.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 3

II.2.1) Title

Lot 3: Mini-Competition

II.2.2) Additional CPV code(s)

33100000

33110000

33111000

33111800

33124120

33151200

33696000

33696800

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

One or more contracting authorities that wish to commit in advance to purchasing a particular value/volume or both of their requirements from Lot 1 and/or Lot 2 may enter into a further competition to do so pursuant to this lot on an aggregated basis. All Tenderers awarded on to Lots 1 and 2 will be automatically awarded on to Lot 3 if they confirm interest during their submission.

Terms and conditions/activity based income (ABI)

The terms and conditions of this framework agreement and any resulting call-off contract is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this framework agreement, the management and administration by HTE of the overall contract structure and associated documentation, as well as the requirement to submit regular management information to HTE.

Submission of expressions of interest and procurement information.

This exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows: register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk Login to the portal with username/password. Click the SQs/ITTs Open to All Suppliers link. These are the SQs/ITTs open to any registered supplier. Click on the relevant SQ/ ITT to access the content. Click the Express Interest button at the top of the page. This will move the SQ/ITT into your My SQs/My ITTs page. You can access any attachments by clicking Buyer Attachments in the SQ/ITT Details box. Follow the onscreen instructions to complete the SQ/ITT. Submit your reply using the Submit Response button at the top of the page. If you require any further advice, contact the Bravo eTendering Help Desk at help@bravosolution.co.uk Sid4Gov HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at sid4gov@gps.gsi.gov.uk Please note that sid4gov does not pre-populate any fields of the SQ on HTE's Bravo portal. Candidates must complete the qualification and technical envelopes of the SQ in Bravo in full.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6) Estimated value

Value excluding VAT: 13 000 000.00 GBP

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24

This contract is subject to renewal: Yes

Description of renewals:

The framework agreement resulting from this procurement process will remain in force for an initial period of 2 years and subject to approval by HealthTrust Europe may be extended for up to a 24-month period thereafter.

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

The framework agreement resulting from this procurement process will remain in force for an initial period of 2 years and subject to approval by HealthTrust Europe may be extended for up to a 24-month period thereafter.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents

III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement with several operators.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 02/03/2020

Local time: 15:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date stated for receipt of tender)

IV.2.7) Conditions for opening of tenders

Date: 02/03/2020

Local time: 15:01

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: Yes

Estimated timing for further notices to be published:

Four years.

VI.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

VI.3) Additional information

HTE is a central purchasing body who is able to carry out this tender exercise by virtue of its appointment as an agent of UHCW. Notwithstanding HTE’s relationship with UHCW, it is HTE conducting this tender exercise and will execute the resultant framework agreement with successful bidders. The bodies to whom the use of this framework agreement will be open include all contracting authorities in the UK as defined in Regulation 2 of the Public Contracts Regulations 2015 as may be updated from time to time. In particular, the following entities in the UK (particularly those of a health and/or social care nature) are envisaged as framework agreement users:

1) All national health service (NHS) bodies in England, including but not limited to:

(i) acute trusts (as listed at: http://www.nhs.uk/servicedirectories/pages/acutetrustlisting.aspx);

(ii) health and care trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx);

(iii) mental health trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/MentalHealthTrustListing.aspx);

(iv) clinical commissioning groups (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx);

(v) ambulance trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx);

(vi) area teams (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx);

(vii) special health authorities (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx);

(viii) NHS England; and

(ix) clinical senates and strategic clinical networks.

2) All NHS bodies in Wales, including but not limited to all:

(i) health boards;

(ii) NHS trusts;

(iii) the national delivery group;

(iv) community health councils; and

(v) NHS Wales shared services partnership (as listed at http://www.wales.nhs.uk/nhswalesaboutus/structure).

3) All NHS bodies in Northern Ireland (known as Health & Social Care), including but not limited to:

(i) health and social care trusts (as listed at: http://online.hscni.net/?s=Trust);

(ii) health agencies (as listed at: http://online.hscni.net/?s=health+agencies);

(iii) hospitals (as listed at: http://online.hscni.net/?s=hospitals); and

(iv) the health and social care board.

4) Social enterprises under taking some or all of the previous service provider functions of contracting authorities in relation to health and/or social care services (including charitable incorporated organisations, cooperatives, industrial and provident societies and community interest companies listed on the Companies House web check service);

5) Ministerial departments and non-ministerial departments of central government, non-departmental agencies and other public bodies and public corporations (as listed at: https://www.gov.uk/government/organisations);

6) Devolved governmental and parliamentary organisations within the UK, including but not limited to the Scottish Government, Scottish Parliament, and Scottish public bodies (as listed at: http://www.scotland.gov.uk/Topics/Government/public-bodies/about/Bodies), as well as the Welsh Government, Welsh Assembly and Welsh unitary authorities (as listed at: http://www.assembly.wales/en/abthome/role-of-assembly-how-it-works/Pages/governance-of-wales.aspx);

7) All local authorities (as listed at: http://local.direct.gov.uk/LDGRedirect/Start.do?mode=1);

8) The Ministry of Defense (as detailed at: https://www.gov.uk/government/organisations/ministry-ofdefence). This list includes each organisation’s successors and assigns, any equivalent organisations and associated organisation created due to any organisational changes. This framework agreement will be open to any bodies or organisations operating in the UK of a health and/or social care nature or which have a similar procurement need and/or any UK based central government authority listed at Annex of Directive 2014/24/EU, in respect of any goods or services to any of the above listed organisations.

VI.4) Procedures for review

VI.4.1) Review body

HealthTrust Europe

19 George Road

Edgbaston

B15 1NU

UK

Telephone: +44 08458875000

VI.4.2) Body responsible for mediation procedures

HealthTrust Europe

19 George Road

Edgbaston

B15 1NU

UK

Telephone: +44 08458875000

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

HealthTrust Europe will incorporate a standstill period at the point information on the award of the contract is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into.

VI.4.4) Service from which information about the review procedure may be obtained

HealthTrust Europe

19 George Road

Edgbaston

B15 1NU

UK

Telephone: +44 08458875000

VI.5) Date of dispatch of this notice

31/01/2020

Current Notes